TATVA / Q3-FY26 / risks

Keep the risk register visible.

Tatva Chintan Pharma Chem · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ3-FY26 · 2026-01-28Back to quarter ↗

Risk intelligence

Material risks this quarter

Agrochemical demand recovery uncertainty

Competitor SRF flagged continued pricing pressure and uncertain recovery in crop protection chemicals. While management believes its innovative technology differentiates from conventional players, any prolonged downturn in agrochemical demand could impact the heavily bet growth strategy.

medium

Geopolitical tariffs and global economic uncertainty

Management acknowledged fluid discussions around reciprocal tariffs in the US and geopolitical tensions. While deemed manageable for near-term trajectory, these factors could impact global chemical demand and supply chains.

medium

SDA segment demand cyclicality and inventory patterns

SDA business operates on campaign-based demand which can cause significant quarter-to-quarter volatility. One quarter could see zero sales followed by hundreds of tons of demand, making sequential tracking unreliable and inventory management challenging.

medium

Semiconductor trial execution risk

First plant-scale trial order for semiconductor chemicals involves only three batches of 3 metric tons each. Customer may not ultimately use the product; success is critical but validation spans 2028 for full commercialization with uncertain outcomes.

low